Home > Healthcare > Medical Devices > Therapeutic Devices > Radiofrequency Ablation Devices Market

Radiofrequency Ablation Devices Market Size

  • Report ID: GMI6323
  • Published Date: Jul 2023
  • Report Format: PDF

Radiofrequency Ablation Devices Market Size

Radiofrequency Ablation Devices Market size was valued at USD 4.3 billion in 2022 and is estimated to account for USD 10.4 billion by 2032. Radiofrequency ablation is a medical technique that involves using high-frequency electrical currents to generate heat and target specific tissues in the body.

 

These devices are utilized to create controlled lesions or destroy abnormal tissue growths without the need for traditional open surgery. The radiofrequency ablation procedure is typically performed using specialized catheters or probes that deliver the radiofrequency energy to the intended area. The market is witnessing lucrative expansion because of the increasing prevalence of chronic diseases, rising demand for minimally invasive treatments, and advancements in medical technology. These devices offer several advantages, such as reduced patient recovery time, decreased risk of complications, and improved treatment outcomes.

 

Advancements in RF ablation technology will enhance the development of sophisticated and precise devices. As, modern RF ablation devices can accurately target specific tissues, tumors, or nerves, while minimizing damage to surrounding healthy tissues. This increased precision has improved treatment outcomes and reduced the risk of complications. Furthermore, the miniaturization of RF ablation devices and the development of more flexible and maneuverable catheters that provide ease of use for healthcare providers to access challenging anatomical locations, perform complex procedures, and improve patient comfort during the treatment.

 

Moreover, the integration of RF ablation devices with advanced medical imaging technologies such as ultrasound, CT scans, and MRI allows real-time visualization of the treatment area, enhancing accuracy and providing immediate feedback to the medical team during the procedure. Additionally, RF ablation devices offer multiple treatment modalities, combining radiofrequency energy with other techniques including microwave ablation or cryoablation for precise disease treatment.

/* disable inspect element start */ /* */ /* end disable inspect element start */ /*

Click here to buy sections of this report


*/
Authors: Mariam Faizullabhoy , Pratiksha Kamthe

Frequently Asked Questions (FAQ) :

Radiofrequency ablation devices market size reached USD 4.3 billion in 2022 and will record USD 10.4 billion by 2032 due to the increasing prevalence of chronic diseases, growing demand for minimally invasive treatments and higher advancements in medical technology

The hospitals segment is predicted to observe 9.3% CAGR from 2023-2032 owing to advantages, such as shorter hospital stays, faster patient recovery, and reduced risk of complications.

U.S. industry size was USD 1.6 billion in revenue size in 2022 and is predicted to witness substantial market growth through 2032 owing to the growing prevalence of chronic diseases such as cancer, diabetes and cardiovascular conditions

Some of the major radiofrequency ablation device providers include Avanos Medical, Inc., Stryker Corporation, Abbott Laboratories, Inc., Medtronic, Plc., Boston Scientific Corporation, Becton, Dickinson and Company (Venclose, Inc.), AngioDynamics, Inc., Hologic, Inc., and AtriCure, Inc.,

Radiofrequency Ablation Devices Market Scope

Buy Now


Premium Report Details

  • Base Year: 2022
  • Companies covered: 15
  • Tables & Figures: 347
  • Countries covered: 30
  • Pages: 267
 Download Free Sample